We found that patients with positive expression of PD-1, PD-L1 and of cAMP had worse cancer-specific mortality (Fig. 1) and these findings were also present in the sub-cohort of patients with locally advanced (pT3-4) and/or positive lymph nodes disease BC (Fig. 2). Here, CD274 is linked to breast cancer.